Researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality. Griffith University researchers are on the brink of a technological ...
WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new ...
Endogenous RNA is central to protein control and, ultimately, cellular function. Synthetic RNA is an important tool for biological research and is also offering a new generation of promising ...
What keeps Joseph Makowiecki excited is the recurrent need for multilayered connectivity in bioprocess development and manufacturing, particularly when it comes to new therapeutic modalities, flexible ...
A pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of ...
Diagnostic imaging is indispensable in healthcare, as it allows clinicians to detect and diagnose a variety of medical conditions. Despite significant advances to imaging technology, however, existing ...
Join host Neil Lander on Chromatography Life as he interviews, Arnaud Delobel, R&D and Innovation Director at Quality Assistance. They discuss the challenges of chromatographic analysis for new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback